Approved anti-PD-1 monoclonal antibodies in China: A bridge too far for US approval. (July 2022)
- Record Type:
- Journal Article
- Title:
- Approved anti-PD-1 monoclonal antibodies in China: A bridge too far for US approval. (July 2022)
- Main Title:
- Approved anti-PD-1 monoclonal antibodies in China: A bridge too far for US approval
- Authors:
- Lythgoe, Mark P.
Sullivan, Richard - Abstract:
- Is Part Of:
- European journal of cancer. Volume 169(2022)
- Journal:
- European journal of cancer
- Issue:
- Volume 169(2022)
- Issue Display:
- Volume 169, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 169
- Issue:
- 2022
- Issue Sort Value:
- 2022-0169-2022-0000
- Page Start:
- 103
- Page End:
- 105
- Publication Date:
- 2022-07
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejca.2022.03.030 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21755.xml